15
Views
8
CrossRef citations to date
0
Altmetric
Research Article

A double-blind controlled trial of mianserin and amitriptyline in depression

, &
Pages 14-22 | Received 27 May 1980, Published online: 11 Aug 2008

References

  • Braithwaite R. A., Nakro B. R. S., Gaind R. Steady state plasma concentrations during single and multiple dosage schedules of amitriptyline. Psychol. Med. 1974; 4: 338–3411. Braithwaite R. A., Nakro B. R. S., Gaind R. Steady state plasma concentrations during single and multiple dosage schedules of amitriptyline. Psychol. Med. 1974; 4: 338–341
  • Coppen A., Gupta R., Montgomery S., Ghose K., Bailey J., Burns B., De Ridder J. J. Mianserin hydrochloride: a novel antidepressant. Br. J. Psychiatry 1976; 129: 342–3452. Coppen A., Gupta R., Montgomery S., Ghose K., Bailey J., Burns B., De Ridder J. J. Mianserin hydrochloride: a novel antidepressant. Br. J. Psychiatry 1976; 129: 342–345
  • Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 563. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56
  • Jaskari M. O., Ahlfors U. G., Ginman L., Lydecken K., Tienari P. Three double-blind comparative trials of mianserin (Org. GB94) and amitriptyline in the treatment of depressive illness. Pharmakopsychiatr. Neuropsychopharmakol. 1977; 10: 101–1034. Jaskari M. O., Ahlfors U. G., Ginman L., Lydecken K., Tienari P. Three double-blind comparative trials of mianserin (Org. GB94) and amitriptyline in the treatment of depressive illness. Pharmakopsychiatr. Neuropsychopharmakol. 1977; 10: 101–103
  • Montgomery S., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a doubleblind trial comparing a single night-time and divided daily dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S–76S, Suppl. 15. Montgomery S., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a doubleblind trial comparing a single night-time and divided daily dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S–76S, Suppl. 1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.